|Bid||0.00 x 1200|
|Ask||0.00 x 800|
|Day's range||31.21 - 32.43|
|52-week range||26.92 - 66.31|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
The bigger issue in Oak Street Health's Q3 update was that the company revealed that the U.S. Department of Justice (DOJ) is investigating whether it may have violated the False Claims Act. The DOJ has requested documents and information related to Oak Street providing free transportation to federal healthcare beneficiaries and related to its relationships with third-party marketing agents. It's too early to know what will happen with the DOJ investigation.
Oak Street Health, Inc. (OSH) delivered earnings and revenue surprises of -4.26% and 8.73%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Oak Street Health (OSH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.